Thursday, December 4, 2025

Aging Drives Increase in Benign Prostatic Hyperplasia Cases Across MENA

Similar articles

The prevalence of benign prostatic hyperplasia (BPH) in the Middle East and North Africa (MENA) region has surged, underscoring the significant impact of an aging population on public health. Recent data from the Global Burden of Disease 2021 database highlight a growing challenge for healthcare systems across multiple countries.

Rising Numbers Highlight Regional Health Trends

In 2021, an estimated 4.7 million individuals in the MENA region were diagnosed with BPH, resulting in an age-standardised prevalence rate of 2,168.6 per 100,000 population. Countries such as Jordan, Qatar, and Iran reported the highest incidence rates, whereas Egypt and Yemen observed comparatively lower figures. These statistics reflect underlying demographic shifts and the increasing longevity of populations within the region.

Subscribe to our newsletter

Age and Socioeconomic Factors Drive Disease Burden

The burden of BPH intensifies with advancing age, reaching its peak in the 65-69 age bracket. This trend correlates with the sociodemographic index (SDI) variations, where higher SDI countries exhibit greater prevalence rates. The years lived with disability (YLDs) attributable to BPH also demonstrate a notable increase, totaling 93.6 thousand with an age-standardised rate of 42.8 per 100,000.

Key Inferences:

  • Countries with higher SDIs like Jordan, Qatar, and Iran face greater BPH prevalence.
  • A significant rise in BPH cases aligns with the region’s aging demographics.
  • Lower SDI countries such as Egypt and Yemen show reduced BPH incidence, potentially due to differing healthcare infrastructures.

Addressing the escalating burden of BPH requires comprehensive public health strategies tailored to the unique demographic and socioeconomic landscapes of the MENA region. Early detection programs, preventive measures, and effective management protocols are essential to mitigate the strain on healthcare systems and improve the quality of life for affected individuals. Investing in medical research and enhancing healthcare accessibility will be pivotal in controlling the spread and impact of BPH. Furthermore, raising awareness about the condition can lead to earlier diagnoses and more effective treatments, ultimately reducing the overall disease burden.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article